Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suxamethonium dose comparison for post-ECT myalgia
ACTRN12609000072213Phase 4Not yet recruiting
- Sponsor
- Peninsula Health
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of succinylcholine (2 arms), sponsored by Peninsula Health. Planned start Feb 2009; status: not yet recruiting.
02
Drugs
succinylcholine
Beyond the preview
Go deeper on ACTRN12609000072213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000072213.